Funded Tech Companies
LimmaTech Biologics
Headquartered in Schlieren, LimmaTech Biologics has funding from Tenmile, private investors and AXA Investment Managers.
Company Overview
Company Name
LimmaTech Biologics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Grabenstrasse 3
Schlieren, 8952
CH
Schlieren, 8952
CH
Phone
Website
Email Address
Company Background Information
Overview
LimmaTech was founded in 2015 as a spin-off from GlycoVaxyn. We are applying our deep expertise in engineering complex carbohydrate molecules to develop next-generation vaccines to prevent life-threatening diseases. Our proprietary pipeline is focused on diseases with emerging antimicrobial resistance (AMR).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/1/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Franz Haas
Chief Financial Officer
Paul Wolfrom
Co-Founder
Michael Kowarik
Company Investors
- Tenmile
- AXA Investment Managers (Zina Besse)
- Adjuvant Capital (Kabeer Aziz)
- Novo Holdings (Camilla Hansen)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs